Clinical trial / 2012
Curcumin treatment improved rheumatoid arthritis disease activity scores more than diclofenac sodium.
A pilot trial randomized 45 patients with active rheumatoid arthritis to receive 500 mg curcumin, 50 mg diclofenac sodium, or their combination. All three groups achieved statistically significant improvements in Disease Activity Scores. Patients receiving curcumin alone showed the largest percentage improvements in overall disease activity and American College of Rheumatology scores, performing significantly better than the diclofenac sodium group without adverse events.
- Study type
- Randomized controlled trial
- Who was studied
- 45 patients with active rheumatoid arthritis
- What was measured
- Disease Activity Score 28 and joint tenderness and swelling scores
THE PAPER
A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis.
Chandran B, Goel A. Phytother Res, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.